Subtopic Deep Dive
Neutrophil-to-Lymphocyte Ratio in Cancer Prognosis
Research Guide
What is Neutrophil-to-Lymphocyte Ratio in Cancer Prognosis?
The neutrophil-to-lymphocyte ratio (NLR) is a blood-based inflammatory biomarker calculated as neutrophils divided by lymphocytes, used to predict survival and treatment response in cancer patients.
NLR thresholds above 3-5 associate with poor prognosis across solid tumors like lung, breast, and colon cancers. Meta-analyses confirm elevated NLR predicts worse overall survival (Cupp et al., 2020; Ethier et al., 2017). Over 50 systematic reviews and 10,000 cohort studies validate its utility since 2014.
Why It Matters
NLR enables risk stratification in oncology, guiding immune checkpoint inhibitor (ICI) selection; Mezquita et al. (2018) showed dNLR >3 combined with LDH predicts poor ICI outcomes in NSCLC (915 citations). Ethier et al. (2017) meta-analysis in breast cancer linked high NLR to reduced survival (674 citations). Templeton et al. (2014) established related PLR's prognostic role in solid tumors, supporting NLR's cost-free integration into clinical workflows for 1M+ annual cancer diagnoses.
Key Research Challenges
Optimal NLR Threshold Variability
NLR cut-offs vary by cancer type and population, lacking universal standards (Záhorec, 2021). Buonacera et al. (2022) note no precise value identified across diseases despite 843 citations. Meta-analyses like Cupp et al. (2020) highlight heterogeneity in 646 reviewed studies.
Confounding by Comorbidities
Infections and treatments alter NLR independently of tumor burden (Azab et al., 2014). Shen et al. (2014) meta-analysis found intratumoral neutrophils confound peripheral NLR signals. Valero et al. (2021) showed mutational burden interacts with pretreatment NLR in ICI response.
Limited Mechanistic Insights
NLR reflects systemic inflammation but tumor microenvironment roles remain unclear (Kim and Bae, 2016). Uribe-Querol and Rosales (2015) describe tumor-associated neutrophils' dual pro- and anti-tumor effects. Cupp et al. (2020) umbrella review calls for causal studies beyond associations.
Essential Papers
Association of the Lung Immune Prognostic Index With Immune Checkpoint Inhibitor Outcomes in Patients With Advanced Non–Small Cell Lung Cancer
Laura Mezquita, Édouard Auclin, Roberto Ferrara et al. · 2018 · JAMA Oncology · 915 citations
Pretreatment LIPI, combining dNLR greater than 3 and LDH greater than ULN, was correlated with worse outcomes for ICI, but not for chemotherapy, suggesting that LIPI can serve as a potentially usef...
Neutrophil to Lymphocyte Ratio: An Emerging Marker of the Relationships between the Immune System and Diseases
Agata Buonacera, Benedetta Stancanelli, Michele Colaci et al. · 2022 · International Journal of Molecular Sciences · 843 citations
Over the last 10 years, the evaluation of the neutrophil-to-lymphocyte ratio (NLR) as an emerging marker of diseases has become a compelling field of bio-medical research. Although a precise and un...
Tumor-Associated Macrophages and Neutrophils in Tumor Microenvironment
Jaehong Kim, Jong‐Sup Bae · 2016 · Mediators of Inflammation · 828 citations
Distinct tumor microenvironment forms in each progression step of cancer and has diverse capacities to induce both adverse and beneficial consequences for tumorigenesis. It is now known that immune...
Neutrophil-to-lymphocyte ratio, past, present and future perspectives
Roman Záhorec · 2021 · Bratislavské lekárske listy/Bratislava medical journal · 801 citations
In the review we analyzed short history of the establishment of a novel hematological parameter for systemic inflammation and stress coined as a neutrophil to lymphocyte ratio (NLR). Today NLR is w...
Prognostic Role of Platelet to Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis
Arnoud J. Templeton, Olga Ace, Mairéad G. McNamara et al. · 2014 · Cancer Epidemiology Biomarkers & Prevention · 691 citations
Abstract Background: Inflammation influences cancer development and progression. An elevated platelet to lymphocyte ratio (PLR), a marker of inflammation, has been linked to poor prognosis in sever...
Prognostic role of neutrophil-to-lymphocyte ratio in breast cancer: a systematic review and meta-analysis
Josee-Lyne Ethier, Danielle Desautels, Arnoud J. Templeton et al. · 2017 · Breast Cancer Research · 674 citations
Neutrophil to lymphocyte ratio and cancer prognosis: an umbrella review of systematic reviews and meta-analyses of observational studies
Meghan A. Cupp, Margarita Cariolou, Ioanna Tzoulaki et al. · 2020 · BMC Medicine · 646 citations
Reading Guide
Foundational Papers
Start with Templeton et al. (2014) meta-analysis on PLR in solid tumors (691 citations) for inflammation-prognosis framework, then Azab et al. (2014) for NLR baselines by race, and Shen et al. (2014) for tumor neutrophil meta-data.
Recent Advances
Prioritize Cupp et al. (2020) umbrella review (646 citations) for synthesis, Valero et al. (2021) on NLR in ICI (432 citations), and Buonacera et al. (2022) on emerging roles (843 citations).
Core Methods
Compute NLR as neutrophils/lymphocytes; apply ROC for cut-offs; Cox regression for HRs; I² for meta-heterogeneity; combine with LDH/dNLR in LIPI scores (Mezquita et al., 2018).
How PapersFlow Helps You Research Neutrophil-to-Lymphocyte Ratio in Cancer Prognosis
Discover & Search
Research Agent uses searchPapers('neutrophil lymphocyte ratio cancer prognosis meta-analysis') to retrieve Cupp et al. (2020) umbrella review (646 citations), then citationGraph reveals 50+ connected meta-analyses like Ethier et al. (2017). exaSearch uncovers cohort data across 250M+ OpenAlex papers, while findSimilarPapers links Mezquita et al. (2018) LIPI to NLR variants.
Analyze & Verify
Analysis Agent applies readPaperContent on Mezquita et al. (2018) to extract dNLR>3 hazard ratios, then verifyResponse with CoVe cross-checks against Templeton et al. (2014) PLR data. runPythonAnalysis computes meta-analytic survival curves from extracted HRs using pandas survival stats, with GRADE grading assigns high evidence to NLR in NSCLC (Mezquita et al., 2018).
Synthesize & Write
Synthesis Agent detects gaps like missing colon cancer NLR thresholds via contradiction flagging across Shen et al. (2014) and Stotz et al. (2013). Writing Agent uses latexEditText for prognostic table drafts, latexSyncCitations integrates 20 papers, and latexCompile generates polished reviews. exportMermaid visualizes NLR survival forest plots from meta-analyses.
Use Cases
"Extract NLR survival data from 10 lung cancer papers and meta-analyze hazard ratios"
Research Agent → searchPapers → readPaperContent (Mezquita 2018 et al.) → Analysis Agent → runPythonAnalysis (pandas Cox regression on HRs) → CSV of pooled HR=1.8 (95% CI 1.5-2.1).
"Write LaTeX review section on NLR cut-offs in breast cancer prognosis"
Synthesis Agent → gap detection (Ethier 2017) → Writing Agent → latexEditText + latexSyncCitations (6 papers) → latexCompile → PDF section with threshold table.
"Find open-source code analyzing NLR from TCGA datasets"
Research Agent → paperExtractUrls (Buonacera 2022) → Code Discovery → paperFindGithubRepo → githubRepoInspect → R script for NLR computation from RNA-seq counts.
Automated Workflows
Deep Research workflow runs systematic review: searchPapers(50 NLR cancer papers) → citationGraph → GRADE all → structured report with pooled OS HRs from Cupp et al. (2020). DeepScan applies 7-step CoVe to verify Valero et al. (2021) NLR-ICI claims against 20 cohorts. Theorizer generates hypotheses linking NLR to TAN polarization from Kim and Bae (2016).
Frequently Asked Questions
What is the neutrophil-to-lymphocyte ratio (NLR)?
NLR is neutrophils count divided by lymphocytes count from routine bloodwork, with values >3-5 indicating high inflammation (Záhorec, 2021).
What methods validate NLR in cancer prognosis?
Meta-analyses pool HRs from cohorts; Ethier et al. (2017) analyzed 20 breast cancer studies showing HR=1.6 for OS, while Cupp et al. (2020) umbrella review synthesized 67 NLR metas.
What are key papers on NLR in cancer?
Mezquita et al. (2018) established LIPI with dNLR in ICI NSCLC (915 citations); Cupp et al. (2020) umbrella review confirmed poor prognosis across tumors (646 citations); Templeton et al. (2014) set PLR baseline (691 citations).
What open problems exist in NLR research?
Standardizing race-specific cut-offs (Azab et al., 2014); clarifying neutrophil tumor roles (Uribe-Querol and Rosales, 2015); prospective RCTs beyond associations (Buonacera et al., 2022).
Research Inflammatory Biomarkers in Disease Prognosis with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Neutrophil-to-Lymphocyte Ratio in Cancer Prognosis with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers